Labcorp Holdings Inc. (LH)
(Delayed Data from NYSE)
$276.07 USD
+1.98 (0.72%)
Updated Sep 17, 2025 04:00 PM ET
After-Market: $276.14 +0.07 (0.03%) 7:34 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
LH 276.07 +1.98(0.72%)
Will LH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LH
LH Stock Rises on Acquisition of BioReference Health's Select Assets
Danaher's Life Sciences Segment Shrinks: What's the Path Forward?
LH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Labcorp Holdings (LH) is a Strong Growth Stock
Danaher's Biotechnology Growth Picks Up: A Sign of More Upside?
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
Other News for LH
Is LH primed for upward momentum? 1,2,3 Pullback Bullish shows up after declining 0.48%
Labcorp Holdings: Currently Priced For Cash And Growth
Is LH ready to move lower? Fell Below 20 Day Moving Average shows up after sliding 0.92%
1,2,3 Pullback Bullish appears for LH after 0.63% move
Crossed Above 20 Day Moving Average appears for LH after 2.48% move